Vasopressin

Cardio/Vascular

Evidence grade

AFDA-approved Rx (labeled use)

Cardiovascular · 0–5 · separate axis

PurposeCritical care

MechanismV1/V2 agonist; vasoconstriction and water retention

EffectsV1/V2 agonist; vasoconstriction and water retention

DosingNo human dose established.

Bottom lineStrongest data when used for its labeled indication under clinician guidance.

Batches on filenone

No tested batches on file.

Read with10

Cautions & interactions

Severe ischemic risks; ICU-only

ICU-only; vasoconstriction—drug interactions managed in hospital protocols.

CV 3 of 5 — Clinically important in acute care settings; not a chronic 'heart health' therapy.